ImmunogenX, Inc.

Industry

  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
See more in Biomedtracker

Latest on ImmunogenX, Inc.

Scrip

Finance Watch: Lykos Implements 75% Workforce Reduction After FDA Rejection

 
• By Mandy Jackson

Lykos Therapeutics , still reeling from US Food and Drug Administration rejection of the company’s capsule formulation of the psychedelic drug midomafetamine for the treatment of post-traumatic stress

Scrip

First Wave To Merge With ImmunogenX With Focus On Celiac Disease

 
• By Joseph Haas

Recently troubled First Wave BioPharma, Inc. is adding pipeline and clinical development capability in an all-stock merger with privately held ImmunogenX , a deal announced on 18 December that will